AI screening for fatty liver disease using CT scans
Part of Digestive system clinical trials.
This study uses artificial intelligence to help doctors identify fatty liver disease from CT scans you may already be having. If eligible, you'll have some blood tests and possibly an ultrasound or MRI to confirm liver health, helping catch liver disease early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having or recently had a chest or belly CT scan with good image quality
- You have recent blood work (ALT, AST, platelets) from the past month, or are willing to get these blood tests done
- You are willing to have an additional ultrasound (FibroScan) or MRI scan to check liver scarring if needed
- You do not have known liver cancer, cirrhosis, or a history of liver transplant or major liver surgery
- You are not currently pregnant or breastfeeding and do not have severe acute illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well primary care doctors can screen for advanced liver scarring in people with fatty liver from non-alcohol causes or from alcohol use. It may help find liver problems earlier so you can get the right follow-up.
This study tests whether an AI tool can help doctors read CT scans of the liver to find cancerous spots. If you have had a CT scan of your abdomen with specific timing, you might be able to join.
This trial uses an AI tool to review routine heart ultrasound images and find people who may be at high risk for fatty liver disease or cirrhosis. It aims to connect participants with further testing and care.
This study uses advanced ultrasound imaging and artificial intelligence to assess heart health in people with fatty liver disease (a condition where fat builds up in the liver). The goal is to better manage heart disease risk in these patients.
This study compares an artificial intelligence tool against a standard liver scan scoring system (LI-RADS) to diagnose liver cancer (HCC) on CT scans. It may help make liver cancer detection more accurate for people at higher risk.
This study uses artificial intelligence to analyze CT scans before and during liver surgery. It aims to build a decision-making system to help doctors better plan and perform surgery for liver cancer or other growths.
Hear when a new Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.